Details for New Drug Application (NDA): 209642
✉ Email this page to a colleague
NDA 209642 describes MAGNESIUM SULFATE IN PLASTIC CONTAINER, which is a drug marketed by Amneal, Baxter Hlthcare Corp, Fresenius Kabi Usa, Gland, Hospira, Hq Spclt Pharma, Milla Pharms, and Mylan Labs Ltd, and is included in eight NDAs. It is available from twelve suppliers. Additional details are available on the MAGNESIUM SULFATE IN PLASTIC CONTAINER profile page.
The generic ingredient in MAGNESIUM SULFATE IN PLASTIC CONTAINER is magnesium sulfate. There is one drug master file entry for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the magnesium sulfate profile page.
The generic ingredient in MAGNESIUM SULFATE IN PLASTIC CONTAINER is magnesium sulfate. There is one drug master file entry for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the magnesium sulfate profile page.
Summary for 209642
| Tradename: | MAGNESIUM SULFATE IN PLASTIC CONTAINER |
| Applicant: | Milla Pharms |
| Ingredient: | magnesium sulfate |
| Patents: | 0 |
Suppliers and Packaging for NDA: 209642
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 209642 | ANDA | Athenex Pharmaceutical Division, LLC. | 70860-501 | 70860-501-81 | 24 POUCH in 1 CARTON (70860-501-81) / 1 BAG in 1 POUCH (70860-501-41) / 50 mL in 1 BAG |
| MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 209642 | ANDA | Athenex Pharmaceutical Division, LLC. | 70860-501 | 70860-501-82 | 24 POUCH in 1 CARTON (70860-501-82) / 1 BAG in 1 POUCH (70860-501-42) / 100 mL in 1 BAG |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 2GM/50ML (40MG/ML) | ||||
| Approval Date: | Nov 8, 2021 | TE: | AP | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 4GM/100ML (40MG/ML) | ||||
| Approval Date: | Nov 8, 2021 | TE: | AP | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 4GM/50ML (80MG/ML) | ||||
| Approval Date: | Nov 8, 2021 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
